A carcinoid tumor associated with chylous ascites and elevated tumor markers

International Journal of Colorectal Disease

Volumn 17, Issue 3, 2002, Pages 156-160

  Warner, Richard R P ^a   Croen, Edward C ^a   Zaveri, Kiran ^a   Ratner, Lynn ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer antigen 125; Carcinoembryonic antigen; Carcinoid; Chromogranin A; Chylous ascites

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN A; CISPLATIN; CYCLOPHOSPHAMIDE; DIURETIC AGENT; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; FUROSEMIDE; LOMUSTINE; NITRATE; OCTREOTIDE; ORAL ANTIDIABETIC AGENT; THEOPHYLLINE; TUMOR MARKER;

ABDOMINAL PAIN; AGED; ARTICLE; ASCITES FLUID; CANCER CHEMOTHERAPY; CARCINOID; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHYLOUS ASCITES; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; MEDICAL LITERATURE; PARACENTESIS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CARCINOEMBRYONIC ANTIGEN; CARCINOID TUMOR; CHYLOUS ASCITES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; OVARIECTOMY; PERITONEAL NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0036938891     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-001-0367-2     Document Type: Article

References (41)

1. Oberndorfer S (1907) Karzinoide Tumoren des Dünndarms. Frankfurter Z Pathol 1:426-430
2. McCarthy SM, Stark DD, Moss AA, Goldberg HI (1984) Computed tomography of malignant carcinoid. J Comput Assist Tomogr 8:846-850
3. Makridis C, Öberg K, Juhlin C, Rastad J, Johansson H, Lorelius LE, Akerstrom G (1990) Surgical treatment of mid-gut carcinoid tumors. World J Surg 14:377-385
4. Varma JS (1985) Acute chylous ascites with carcinoid of the pancreas. Scott Med J 30:111
5. Mortensen RM, Medoff J, Feldman JM (1988) Case report: chylous ascites and carcinoid tumors: possible association of 2 rare disorders. Am J Med Sci 296:272-274
6. Dumont AE, Libby N (1989) Thoracic duct lymph in a patient with chylous ascites and a carcinoid tumor. Lymphology 22:199-201
7. Anonymous (1986) Case records of the Massachusetts General Hospital; case 20-1986. A 68 year old man with malabsorption, chylous ascites and a mesenteric mass. N Engl J Med 314:1369-1378
8. Sherry S (1959) Clinical pathologic conference: diarrhea, abdominal pain, gastrointestinal bleeding, chylous ascites and an intra-abdominal tumor. Am J Med 26:919-928
9. Hodgson HJF, Sharp EJ, Waxman J, Bloom SR (1993) Grand Rounds-Hammersmith Hospital. A case of chylous ascites. BMJ 307:495-497
10. Kelly ML Jr, Butt HR (1960) Chylous ascites; an analysis of its etiology. Gastroenterology 39:161-70
11. Bigler D, Lublin HFK (1981) Chylous ascites. Ugresk Laeger 143:551
12. Feldman JM (1989) Carcinoid tumor and the carcinoid syndrome. Curr Probl Surg 26:831-898
13. Vasko J, Tapper R (1967) The surgical significance of chylous ascites. Arch Surg 95:355-368
14. Wallis RLM, Schölberg HA (1910) On chylous and pseudo-chylous ascites. Q J Med 4:153-204
15. Tsuchiya M, Okazaki I, Maruyama K, Asakura H, Morita A (1973) Chylous ascites formation and a review of 84 cases. Angiology 24:576-584
16. Lindenbaum J, Scheidt S (1968) Chylous ascites and the nephrotic syndrome. Am J Med 44:830-836
17. Press OW, Press NO, Kaufman SD (1982) Evaluation and management of chylous ascites. Ann Intern Med 96:358-364
18. Kryzek T, Davis J (1965) Acute chylous peritonitis. Arch Surg 91:253-262
19. Bender MD, Ockner RK (1978) Diseases of the peritoneum, mesentery, and diaphragm. In: Sleisenger MH, Fordtran JS (eds) Gastrointestinal diseases, 2nd edn. Saunders, Philadelphia, p 1955
20. Gribetz D, Kanoff A (1951) Chylous ascites in infancy; with report of a case with vitamin A absorption studies. Pediatrics 7:632-641
21. Sanchez RE, Mahour GH, Brennan LP, Woolley MM (1971) Chylous ascites in children. Surgery 69:183-188
22. Feldman JM, Plonk JW (1975) Carcinoembryonic antigen and carcinoid tumors. Ann Intern Med 83:82-83
23. Bishopric GA, Oronez NG (1986) Carcinoembryonic antigen and primary carcinoid tumor of the lung. Cancer 58:1316-1320
24. Klug TL, Bast RC Jr, Niloff JM, Knapp RC, Zurawski VR Jr (1984) Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA-125) associated with human epithelial ovarian carcinomas. Cancer Res 44:1048-1053
25. Malkasian GD Jr, Podratz KC, Stanhope CR, Ritts RE Jr, Zurawski VR Jr (1986) CA-125 in gynecologic practice. Am J Obstet Gynecol 155:515-518
26. Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC Jr (1984) CA-125 antigen levels in obstetric and gynecologic patients. Am J Obstet Gynecol 64:703-707
27. Ricolleau G, Fumoleau P, Kremer M, et al (1983) Advances in cancer research. Presented at the 11th Annual Meeting of the International Society for Oncodevelopmental Biology and Medicine, Stockholm, Sweden, September
28. Carpenter PM, Gamboa GP, Dorion GE, Ramsinghani NS, Aissi AM, Manetta A (1996) Radiation-induced CA-125 production by mesothelial cells. Gynecol Oncol 63:328-332
29. O'Connor DT, Deftos LJ (1986) Secretion of chromogranin-A by peptide producing endocrine neoplasms. N Engl J Med 314:1145-1151
30. Deftos LJ (1991) Chromogranin-A: its role in endocrine function as an endocrine and non-endocrine tumor marker. Endocr Rev 12:181-187
31. Warner RRP, Mani S (1992) A statistical analysis of laboratory and clinical correlations in carcinoid disease. Gastroenterology 102:A407
32. Tiensuu-Janson EM, Öberg K (1996) Carcinoid tumours. Baillieres Clin Gastroenterol 10:589-601
33. 3]-octreotide: the Rotterdam experience with more than 1:000 patients. Eur J Nucl Med 20:716-731
34. Olsen JO, Pozderac RV, Hinkle G, Hill T, O'Dorisio TM, Schirmer WJ, Ellison EC, O'Dorisio MS (1995) Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (octreoscan). Semin Nucl Med 25:251-261
35. Ohrvall U, Westlin JE, Nilsson S, Juhlin C, Rastad J, Lundqvist H, Akerstrom G ( 1997) Intraoperative gamma detection reveals abdominal endocrine tumors more effectively than somatostatin receptor scintigraphy. Cancer 80 [Suppl 12]:2490-2494
36. Kvols LK, Reubi JC, Horisberger U, Moertel CG, Rubin J, Charboneau, JW (1992) The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide. Yale J Biol Med 65:505-518
37. Öberg K (1993) The use of chemotherapy in the management of neuroendocrine tumors. Endocrinol Metab Clin North Am 22:941-952
38. Moertel CG (1987) An odyssey in the land of small tumors. J Clin Oncol 5:1503-1522
39. Anthony L, Johnson D, Hande K, Shaff M, Winn S, Krozely M, Oates J (1993) Somatostatin analogue phase I trials in neuroendocrine neoplasms. Acta Oncol 32:217-223
40. Vinik A, Moattari AR (1989) Use of somatostatin analogue in the management of carcinoid syndrome. Dig Dis Sci [Suppl 34]:14S-27S
41. Kvols LK (1989) Therapy of the malignant carcinoid syndrome. Endocrinol Metab Clin North Am 18:557-568